Skip to main content


Breast Cancer Research and Treatment

Breast Cancer Research and Treatment 3/2016

Ausgabe 3/2016

Inhaltsverzeichnis ( 19 Artikel )

25.08.2016 | Review | Ausgabe 3/2016

Descriptive epidemiology of breast cancer in China: incidence, mortality, survival and prevalence

Tong Li, Claudia Mello-Thoms, Patrick C. Brennan

30.08.2016 | Review | Ausgabe 3/2016

Cost–utility analyses of drug therapies in breast cancer: a systematic review

Virginie Nerich, Sopany Saing, Eva Maria Gamper, Georg Kemmler, Franck Daval, Xavier Pivot, Bernhard Holzner

30.08.2016 | Review | Ausgabe 3/2016

Cost-effectiveness of febrile neutropenia prevention with primary versus secondary G-CSF prophylaxis for adjuvant chemotherapy in breast cancer: a systematic review

T. Younis, D. Rayson, S. Jovanovic, C. Skedgel

29.08.2016 | Preclinical study | Ausgabe 3/2016

Association study confirms two susceptibility loci for breast cancer in Chinese Han women

Minggui Xu, Yihui Xu, Mengyun Chen, Yang li, Wei li, Jun Zhu, Mingjun Zhang, Zhendong Chen, Xuejun Zhang, Jianjun liu, Bo Zhang

29.08.2016 | Preclinical study | Ausgabe 3/2016

Phosphorylation of LSD1 at Ser112 is crucial for its function in induction of EMT and metastasis in breast cancer

Jingxin Feng, Guiying Xu, Jiwei Liu, Na Zhang, Lili Li, Jiafei Ji, Jianchao Zhang, Lian Zhang, Guannan Wang, Xiuli Wang, Jiang Tan, Baiqu Huang, Jun Lu, Yu Zhang

03.09.2016 | Preclinical study | Ausgabe 3/2016 Open Access

Clinicopathological and prognostic significance of mitogen-activated protein kinases (MAPK) in breast cancers

Dena A. J. Ahmad, Ola H. Negm, M. Layth Alabdullah, Sameer Mirza, Mohamed R. Hamed, Vimla Band, Andrew R. Green, Ian O. Ellis, Emad A. Rakha

06.09.2016 | Preclinical Study | Ausgabe 3/2016

Exercise regulates breast cancer cell viability: systemic training adaptations versus acute exercise responses

Christine Dethlefsen, Christian Lillelund, Julie Midtgaard, Christina Andersen, Bente Klarlund Pedersen, Jesper Frank Christensen, Pernille Hojman

27.08.2016 | Clinical trial | Ausgabe 3/2016

Genomic profiling of breast cancer in African-American women using MammaPrint

Raquel A. Nunes, Lynette Wray, Mihriye Mete, Pia Herbolsheimer, Karen L. Smith, Lana Bijelic, Marc E. Boisvert, Sandra M. Swain

02.09.2016 | Clinical trial | Ausgabe 3/2016

Breast cancer-specific mortality in small-sized tumor with node-positive breast cancer: a nation-wide study in Korean breast cancer society

Jai Min Ryu, Hyouk Jin Lee, Tae in Yoon, Eun Sook Lee, Soo Jung Lee, Jin Hyang Jung, Byung Joo Chae, Seok Jin Nam, Jeong Eon Lee, Se Kyung Lee, Soo Youn Bae, Jonghan Yu, Seok Won Kim, Korean Breast Cancer Society Consortium

03.09.2016 | Clinical trial | Ausgabe 3/2016

BIRC5 (survivin): a pejorative prognostic marker in stage II/III breast cancer with no response to neoadjuvant chemotherapy

A. S. Hamy, I. Bieche, J. Lehmann-Che, V. Scott, Ph. Bertheau, J. M. Guinebretière, M. C. Matthieu, B. Sigal-Zafrani, O. Tembo, M. Marty, B. Asselain, F. Spyratos, P. de Cremoux

26.08.2016 | Epidemiology | Ausgabe 3/2016

Breast cancer risk prediction using a clinical risk model and polygenic risk score

Yiwey Shieh, Donglei Hu, Lin Ma, Scott Huntsman, Charlotte C. Gard, Jessica W. T. Leung, Jeffrey A. Tice, Celine M. Vachon, Steven R. Cummings, Karla Kerlikowske, Elad Ziv

31.08.2016 | Epidemiology | Ausgabe 3/2016

A collaborative approach to cancer risk assessment services using genetic counselor extenders in a multi-system community hospital

Stephanie A. Cohen, Dawn M. Nixon

01.09.2016 | Epidemiology | Ausgabe 3/2016

Understanding racial differences in health-related quality of life in a population-based cohort of breast cancer survivors

Laura C. Pinheiro, Cleo A. Samuel, Katherine E. Reeder-Hayes, Stephanie B. Wheeler, Andrew F. Olshan, Bryce B. Reeve

07.09.2016 | Epidemiology | Ausgabe 3/2016

A prospective study of endometriosis and risk of benign breast disease

Leslie V. Farland, Rulla M. Tamimi, A. Heather Eliassen, Donna Spiegelman, Laura C. Collins, Stuart J. Schnitt, Stacey A. Missmer

08.09.2016 | Epidemiology | Ausgabe 3/2016 Open Access

Subsequent risk of ipsilateral and contralateral invasive breast cancer after treatment for ductal carcinoma in situ: incidence and the effect of radiotherapy in a population-based cohort of 10,090 women

Lotte E. Elshof, Michael Schaapveld, Marjanka K. Schmidt, Emiel J. Rutgers, Flora E. van Leeuwen, Jelle Wesseling

29.08.2016 | Brief Report | Ausgabe 3/2016

Cost-effectiveness analysis of trastuzumab emtansine (T-DM1) in human epidermal growth factor receptor 2 (HER2): positive advanced breast cancer

Quang A. Le, Yuna H. Bae, Jenny H. Kang

31.08.2016 | Brief Report | Ausgabe 3/2016

Multiplexed imaging reveals heterogeneity of PI3K/MAPK network signaling in breast lesions of known PIK3CA genotype

Thomas Jacob, Joe W. Gray, Megan Troxell, Tania Q. Vu

31.08.2016 | Brief Report | Ausgabe 3/2016

Ready to clone: CNV detection and breakpoint fine-mapping in breast and ovarian cancer susceptibility genes by high-resolution array CGH

Karl Hackmann, Franziska Kuhlee, Elitza Betcheva-Krajcir, Anne-Karin Kahlert, Luisa Mackenroth, Barbara Klink, Nataliya Di Donato, Andreas Tzschach, Karin Kast, Pauline Wimberger, Evelin Schrock, Andreas Rump

31.08.2016 | Erratum | Ausgabe 3/2016

Erratum to: Exposure to polychlorinated biphenyl (PCB) congeners measured shortly after giving birth and subsequent risk of maternal breast cancer before age 50

Barbara A. Cohn, Mary Beth Terry, Marj Plumb, Piera M. Cirillo

Aktuelle Ausgaben

Neu im Fachgebiet Onkologie

Mail Icon II Newsletter

Bestellen Sie unseren kostenlosen Newsletter Update Onkologie und bleiben Sie gut informiert – ganz bequem per eMail.